ProfileGDS4718 / 222219_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 53% 43% 56% 50% 42% 49% 56% 49% 52% 49% 46% 49% 45% 51% 50% 57% 45% 54% 62% 54% 50% 59% 51% 47% 48% 49% 41% 54% 45% 45% 40% 49% 54% 45% 45% 49% 52% 49% 43% 51% 50% 42% 46% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7538254
GSM549102patient 115, normal, homogenized [OPG study]5.7078153
GSM549104patient 119, normal, homogenized [OPG study]5.1252543
GSM549108patient 138, normal, homogenized [OPG study]5.905356
GSM549119patient 077, normal, homogenized [OPG study]5.5314250
GSM549133patient 032, cancer, homogenized [OPG study]5.0474842
GSM549139patient 042, cancer, homogenized [OPG study]5.4164949
GSM549099patient 107, normal, homogenized [OPG study]5.8635856
GSM549109patient 139, normal, homogenized [OPG study]5.4806649
GSM549110patient 046, normal, homogenized [OPG study]5.6229752
GSM549114patient 063, normal, homogenized [OPG study]5.3852349
GSM549122patient 082, normal, homogenized [OPG study]5.2911446
GSM549134patient 033, cancer, homogenized [OPG study]5.4611849
GSM549136patient 036, cancer, homogenized [OPG study]5.1972145
GSM549140patient 044, cancer, homogenized [OPG study]5.5535451
GSM549111patient 047, normal, homogenized [OPG study]5.4833350
GSM549113patient 057, normal, homogenized [OPG study]5.8725857
GSM549132patient 031, cancer, homogenized [OPG study]5.2222845
GSM549137patient 038, cancer, homogenized [OPG study]5.7196854
GSM549142patient 047, cancer, homogenized [OPG study]6.3169162
GSM549100patient 110, normal, homogenized [OPG study]5.7517954
GSM549107patient 135, normal, homogenized [OPG study]5.5009750
GSM549115patient 068, normal, homogenized [OPG study]6.0343959
GSM549116patient 072, normal, homogenized [OPG study]5.5283851
GSM549120patient 078, normal, homogenized [OPG study]5.3609447
GSM549131patient 030, cancer, homogenized [OPG study]5.3568948
GSM549118patient 074, normal, homogenized [OPG study]5.4636849
GSM549129patient 027, cancer, homogenized [OPG study]5.052141
GSM549123patient 088, normal, homogenized [OPG study]5.7365154
GSM549124patient 006, cancer, homogenized [OPG study]5.2555445
GSM549126patient 015, cancer, homogenized [OPG study]5.2338145
GSM549128patient 025, cancer, homogenized [OPG study]4.9765240
GSM549103patient 117, normal, homogenized [OPG study]5.5176849
GSM549117patient 073, normal, homogenized [OPG study]5.6817254
GSM549138patient 041, cancer, homogenized [OPG study]5.2211945
GSM549141patient 045, cancer, homogenized [OPG study]5.1649845
GSM549130patient 028, cancer, homogenized [OPG study]5.4396249
GSM549101patient 111, normal, homogenized [OPG study]5.6762552
GSM549105patient 128, normal, homogenized [OPG study]5.4684349
GSM549106patient 134, normal, homogenized [OPG study]5.1071543
GSM549112patient 048, normal, homogenized [OPG study]5.5508451
GSM549125patient 011, cancer, homogenized [OPG study]5.4950150
GSM549127patient 024, cancer, homogenized [OPG study]5.0818942
GSM549135patient 035, cancer, homogenized [OPG study]5.2808946